Your APAC Medical Device Distributor Is Underperforming. Can You Protect Your Customers and Revenue?

You have shipped medical devices into an Asia-Pacific market. Your distributor says the market is slow, hospital budgets are delayed and more time is needed. If your Asia-Pacific distributor is missing targets, this article shows how to assess the risk before you renew, restructure or replace them.

But you still cannot answer basic questions with confidence:

• Which hospitals have actually installed your systems?
• Which evaluations are active, and who is making the decision?
• Which customers are using the devices regularly?
• What service, training or supply commitments are outstanding?
• What would happen to those accounts if you changed distributors next quarter?

The distributor has missed its target. The contract renewal is approaching. The pipeline report shows meetings and demonstrations, but few purchase orders. Meanwhile, the customer and installed-base information you need appears to sit inside the distributor’s systems—not yours.

Three different problems can sit behind weak performance

Before deciding what to do, separate three questions.

Is there a market problem? Hospitals may lack sufficient clinical need, budget, urgency or willingness to buy. A replacement distributor cannot solve weak market demand simply by inheriting the same accounts.

Is there an execution problem? The distributor may be failing to qualify accounts, reach decision-makers, progress procurement, support adoption or develop demand.

Is there a control and continuity problem? You may be unable to verify the installed base, service obligations, customer-level activity or the information required to protect accounts during a transition.

These problems can coexist. Start by separating verified information from assumptions that still need validation, then determine whether the gap is primarily market, execution or control.

An example from the region

Consider an example based on a common distributor situation.

A manufacturer had shipped 30 systems into an APAC market. The distributor reported 22 installations and described the remaining eight units as inventory. Reorder activity was weak, so the manufacturer concluded that market demand was disappointing.

A check showed that six systems remained in distributor inventory, while two had been allocated to hospitals without complete installation records. Several installed sites had received limited user training, and one active evaluation had stalled because the hospital’s procurement case had not been completed.

The review did not establish that the distributor was solely responsible for weak demand. It revealed several different issues: inventory that had not reached customers, incomplete installation information, limited user training and a stalled procurement process.

Replacing the distributor might still have been the right decision. But the manufacturer first needed to establish the status of each device, understand which hospital opportunities remained viable and identify any service or customer commitments that could be disrupted.

The lesson: verify the available information before interpreting distributor performance.

The Distributor Continuity Test

The Distributor Continuity Test is a practical KawaHive decision framework—not a scientifically validated diagnostic or predictive model. It helps founders assess four dimensions of exposure before deciding whether to improve, restructure or replace a distributor.

1. Customer access

Can you identify and appropriately engage the accounts that matter?

For each priority account, identify the hospital and department, clinical user or champion, procurement or budget owner, evaluation stage, next action and reason for any delay or loss. A meeting is not the same as access. A demonstration is not the same as a buying process. A named hospital is not the same as a qualified opportunity.

2. Installed-base certainty

Can you verify what is placed, where it is placed and whether it is being used?

For every system shipped or allocated, classify its status as inventory, delivered, commissioned, installed and accepted, actively used, generating recurring orders where applicable, in evaluation, or returned, transferred or unresolved.

Verify distributor information against available serial numbers, delivery confirmations, commissioning and acceptance details, warranty registrations, service reports, training records, customer sites, consumable or spare-parts orders and purchase-order history.

3. Operational continuity

Can service, training, parts and supply continue if the relationship changes?

Identify open service cases, maintenance or calibration requirements, stock and spare-parts locations, technical escalation responsibilities, outstanding training and customers approaching a reorder or renewal. Delayed service can damage clinical confidence, internal referrals and future expansion—not just one order.

4. Financial runway

Can you fund the transition before replacement revenue arrives?

Estimate re-engagement, technical support, interim service coverage, stock transfer, training, administration and account-reconstruction costs. Then model when cash leaves and replacement revenue is realistically expected.

Use the scorecard to identify where the risk sits

The four dimensions above describe the overall risk. The accompanying Distributor Continuity Test assesses these dimensions through 24 scored statements—six statements in each section. The eight practical checks below provide a shorter overview of issues to examine, from hospital access and pipeline quality to installed-base visibility, service continuity and recovery willingness.

Allow approximately 15 minutes to complete the worksheet. Score each of its 24 statements using verifiable information—not confidence in verbal assurances.

• Green: validation is available and the process is working.
• Amber: validation is incomplete, inconsistent or requires corrective action.
• Red: a material risk remains unresolved, or required information is unavailable.

In the worksheet, each statement is scored Green = 2, Amber = 1 or Red = 0. The six statements in each of the four sections contribute up to 12 points, for a maximum total of 48. The score bands are 39–48 (Improve with control), 25–38 (Restructure before you renew) and 0–24 (Prepare for replacement while protecting customers). A critical zero in customer access, installed-base certainty, operational continuity or financial runway requires separate assessment regardless of the total. Use the result to prioritise validation; it is not a scientifically validated diagnostic or an automatic termination rule.

Focus on the pattern, not just the total number of red ratings. A single unresolved service or customer-continuity gap can matter more than several minor reporting issues.

A red rating is a reason to assess the issue and prepare appropriate safeguards. It is not, by itself, proof of misconduct or an automatic reason to terminate the relationship. A missing record may indicate a serious control problem—or a gap that can be resolved quickly.

Assign an owner and deadline to each material gap before deciding what to change.

Choose the response: recover, restructure or replace

The scorecard assesses exposure. The next decision is how to respond.

Recover: how to fix an underperforming distributor

Recovery may be appropriate when the distributor has genuine access to relevant hospitals, installed-base gaps are operational rather than persistent, service obligations are broadly being met, the product has a credible market case and the distributor accepts measurable corrective actions.

Set a time-bound plan with the problem, action, owner, deadline and information required. Possible actions include account requalification, clinical or product training, installation checks, service escalation procedures and monthly opportunity reviews.

Restructure when the relationship has potential but the model is wrong

Restructuring may involve changing territory coverage, assigning a different sales or technical team, adding a second partner for a specific country or segment, separating equipment sales from service responsibilities, introducing customer-level reporting or changing incentives from shipment volume to sell-through and adoption.

A distributor can have relationships but still lack the operating model required to develop your product.

Replace your medical device distributor when critical risks persist

Replacement becomes more compelling when the distributor repeatedly fails essential service obligations, withholds customer or installed-base visibility, lacks relevant clinical and procurement access, reports activity without credible progression or rejects reasonable accountability.

Even then, appointing a new distributor is not the transition plan. It is only one part of it.

Protect, retain and recover during a transition

Protect

Identify urgent service and supply requirements, confirm responsibility for open cases, secure access to critical records, review stock and parts, and identify accounts where disruption could affect patient care, procedures or clinical confidence.

Retain

Prioritise customers approaching a reorder, renewal or maintenance event. Verify contacts and opportunity status, confirm technical support and supply continuity, and monitor accounts showing reduced utilisation or competitor activity.

Recover

Verify the status of every device and priority account, reassess stalled evaluations, assign an owner and next action to each account, and set realistic milestones for re-engagement, purchase orders, reorders and adoption.

Any transition must respect the distributor agreement, applicable privacy and data-protection requirements, customer commitments and relevant local obligations. Customer information, installed-device data, inventory, service responsibilities and rights to transfer account information may be governed differently by country, product and contract. Obtain appropriate legal and local advice before transferring customer information or appointing a replacement.

Model the cash and gross profit at risk

Suppose $200,000 of potential revenue is exposed during a distributor transition. At an assumed gross margin of 40%, that revenue would generate $80,000 in gross profit if all of it were realised under the stated assumptions.

That is an exposure estimate—not a forecast of the loss. The actual outcome depends on how much revenue is lost permanently, delayed but eventually realised, or retained only through additional spending. It also depends on which variable costs are avoided and when transition spending and replacement revenue occur.

Build three scenarios:

• Expected recovery: most priority customers are retained, service continues and replacement orders begin within the expected window.
• Delayed recovery: customer access takes longer to rebuild, evaluations slip and support costs continue for several months.
• Severe downside: some customers move to competitors, recurring orders are interrupted and the incoming distributor requires substantial support.

For example, transition and support costs may be paid in months 1–3, while customer re-engagement, replacement orders and revenue recovery may not begin until months 4–9. That timing gap—not only the total cost—determines whether the business can sustain the transition.

In practice, this can mean carrying support and transition costs for a full quarter before meaningful replacement orders appear. If your current cash position cannot comfortably absorb that lag while still protecting priority accounts, the downside scenario becomes the planning baseline.

The purpose is not to predict perfectly. It is to determine whether your business has enough cash runway to protect customers, maintain essential service and support a credible recovery or transition under a downside scenario.

Financial scenarios are only useful when based on reliable customer, inventory and service data. Use the following questions to check whether you know enough to make the next channel decision.

Before you renew, renegotiate or terminate

Make sure you can answer six questions:

1. Can we identify and appropriately engage the hospital accounts that matter?
2. Can we verify the location and status of every shipped or installed device?
3. Can we distinguish genuine buying progress from meetings and demonstrations?
4. Can we maintain service, training and supply if the relationship changes?
5. Can a replacement partner realistically retain priority accounts?
6. Can we fund the transition if revenue is delayed for six months?

Your regular distributor performance review should provide the information needed to answer these questions: qualified opportunities and next actions, installed-base discrepancies, customer-level sell-through, utilisation and repeat orders where applicable, service performance, stock status and recovery-plan milestones.

If several answers are no, do not assume termination is the immediate answer. Start by identifying the most consequential information gaps and protecting customers from avoidable disruption.

Book a free 30-minute Distributor Risk Review

If your APAC distributor has missed targets, hospital evaluations have stalled or installed-base information is unreliable, KawaHive can help you clarify the exposure before you make a costly channel decision.

In this free session, we will help you identify your three most significant risks, the information you still need and whether recovery, restructuring or preparation for a distributor transition warrants further review.

Bring your completed Distributor Continuity Test, your latest distributor report and whatever shipment or installation figures you have available. You do not need a complete CRM export or a finished transition plan.

If you have not completed the assessment yet, start with the free worksheet in KawaHive Lab.